- Jul 21, 2020
- 1 min read

BioSpace Clinical Catch-Up: July 13-17 (Algernon Pharmaceuticals Inc.)

Algernon Pharmaceuticals completed its clinical trial agreement with Westchester Research Center at Westchester General Hospital in Miami, Florida, for its multinational Phase IIb/III trial of NP-120 (ifenprodil) for COVID-19. The trial is expected to start after July 20.

READ THE FULL ARTICLE HERE

SOURCE

Recent Posts

See All

Revive Therapeutics Provides Update of Phase 3 Clinical Study...

Revive will remain with the current protocol’s primary endpoint of proportion of patients meeting an endpoint of hospitalization or death..

Rakovina Therapeutics to Present at the Emerging Growth Conference on November 30, 2022

Rakovina Therapeutics’ management will deliver a brief corporate overview and then be available for questions and discussions...

Financial Post: Skylight Health Group